NEW YORK (GenomeWeb News) – Swedish firm Addtech Life Science today announced it has acquired BioNordika Holding.
Addtech Life Science is a business area in the Addtech Group. BioNordika Holding is the parent company of the BioNordika Group, which markets reagents and instruments for biomedical research, primarily to the pharmaceutical industry and public institutions.
BioNordika Group has subsidiaries in Denmark, Estonia, Finland, Norway, and Sweden. It has 24 employees and SEK80 million ($11.8 million) in sales.
The purchase is expected to be complementary to Addtech Life Science's Diagnostic Business Unit, which sells reagents and equipment to healthcare laboratories in the Nordic region.
The deal, which closes today, is anticipated to be "marginally" accretive to Addtech Life Science's earnings per share in the current year, it said.
Terms of the acquisition were not disclosed.